"Now that the sale evaluation process is concluded," commented Howard Hoffmann, President and CEO of MedQuist, "we can focus all of our energy and talent on growing top line revenue and bottom line performance through the continued development and delivery of innovative, high quality and cost effective technology and services solutions for our customers."
MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com.
This press release contains forward-looking statements that are based
on current expectations, estimates, forecasts and projections about us, the
industry in which we operate and other matters, as well as management's
beliefs and assumptions and other statements regarding matters that are not
historical facts. These statements include, in particular, statements about
our plans, strategies and prospects. For example, when we use words such as
"projects," "expects," "anticipates," "intends," "plans," "believes,"
"seeks," "estimates," "should," "would," "could," "will," "opportunity,"
"potential" or "may," variations of such words or other words that convey
uncertainty of future events or outcomes, we are making forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933
(Securities Act) and Section 21E of the Exchange Act. These statements are
|SOURCE MedQuist Inc.|
Copyright©2008 PR Newswire.
All rights reserved